Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

PPH Market Vectors Pharmaceutical ETF

  • Fund Description

    Market Vectors® Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors U.S., Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

  •  
      

    • Fund Ticker

      PPH
    • Exchange

      NASDAQ
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVPPHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 02/05/16

    • 30-Day SEC Yield1

      2.00%
    • Total Net Assets

      $340.0M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.41%
    • Net Expense Ratio/TER2

      0.36%
    • Distribution Frequency

      Quarterly
    • Next Distribution Date

      03/31/2016
  • Portfolio Composition (%)
    as of 02/05/16

    • % of Net Assets
    • Stocks

      99.81
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      0.19
  • Download All HoldingsDaily Holdings (%) as of 02/05/16

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Johnson & Johnson
    JNJ US
    276,590
    27,808,3598.18
    Novartis Ag
    NVS US
    310,206
    23,057,6126.78
    Glaxosmithkline Plc
    GSK US
    470,011
    19,157,6485.64
    Pfizer Inc
    PFE US
    624,739
    18,136,1735.33
    Sanofi
    SNY US
    441,879
    17,595,6225.18
    Merck & Co Inc
    MRK US
    352,315
    17,397,3155.12
    Allergan Plc
    AGN US
    60,713
    16,623,2194.89
    Bristol-Myers Squibb Co
    BMY US
    271,207
    16,172,0734.76
    Novo Nordisk A/S
    NVO US
    327,856
    16,032,1584.72
    Abbvie Inc
    ABBV US
    298,737
    15,868,9094.67
    Valeant Pharmaceuticals International I
    VRX US
    157,657
    15,228,0904.48
    Teva Pharmaceutical Industries Ltd
    TEVA US
    255,703
    15,050,6794.43
    Astrazeneca Plc
    AZN US
    500,401
    15,027,0424.42
    Eli Lilly & Co
    LLY US
    199,658
    14,838,5834.36
    Abbott Laboratories
    ABT US
    372,366
    13,930,2124.10
    Mckesson Corp
    MCK US
    89,609
    13,832,0454.07
    Shire Plc
    SHPG US
    84,828
    13,345,1413.93
    Perrigo Co
    PRGO US
    74,049
    10,654,1703.13
    Mylan Inc/Pa
    MYL US
    199,567
    10,255,7483.02
    Zoetis Inc
    ZTS US
    234,223
    9,582,0632.82
    Amerisourcebergen Corp
    ABC US
    95,464
    8,085,8012.38
    Endo Pharmaceuticals Holdings Inc
    ENDP US
    85,191
    4,589,2391.35
    Mallinckrodt Plc
    MNK US
    48,406
    3,363,2490.99
    Jazz Pharmaceuticals Plc
    JAZZ US
    21,304
    2,594,1880.76
    Akorn Inc
    AKRX US
    44,209
    1,115,3930.33
    Other/Cash
    --
    --
    631,2360.19
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.